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Abstract
Purpose: To study the density of lesions in the lumens of extrahepatic bile ducts through computed tomography 
examinations, and to compare their characterisations with the results of pathology and/or endoscopic retrograde 
cholangiopancreatography (ERCP).
Methods: The density of lesions along extrahepatic bile ducts were measured and compared with pathology and/or 
ERCP. The lesions were evaluated in two main groups: benign or malignant. The bile duct wall enhancement, intra-
hepatic bile ducts, and gallbladder were also evaluated. 
Results: The study was conducted with computed tomography scans of 197 cases (93 females, 104 males) who had 
optimal imaging. The results regarding density of extrahepatic intraductal lesions that were studied at BT were com-
pared with pathology and magnetic resonance cholangiopancreatography results. Of 197 lesions, 125 (63.5%) were 
reported as benign and 72 (36.5%) were reported as malignant. The results for benign lesions showed an average 
density of 66.67 ± 17.30 Hounsfield units (HU), and for malignant lesions the average density was 82.38 ± 13.67 HU.
Conclusion: Lesion density level (HU) gives valuable information for the differentiation between benign and malign 
lesions in intraluminal extrahepatic bile ducts.
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Introduction
Bile duct pathologies represent a common group of dis-
eases leading to right upper quadrant pain, jaundice, pru-
ritus, nausea, and vomiting. They may be intrahepatically 
or extrahepatically located. The pathology causing clinical 
or radiological symptoms may have an intraluminal lim-
itation; moreover, it may originate from the wall or be of 
extrabiliary system origin, leading to a bile duct disease 
through pressure and/or invasion.
Ultrasonography (US) and magnetic resonance chol-
angiopancreatography (MRCP) are the primary diag-
nostic methods in cases of bile duct diseases. However, 
computed tomography (CT) provides more detailed 
information on the obstruction level, mass characterisa-
tion, and staging in obstructions due to tumoral lesions. 
CT is a guideway for demonstrating gallstone, stricture, 
inflammation, external pressure, intraluminal or extralu-
minal tumours, and tumour staging [1,2]. The sensitivity 
of CT for demonstrating the obstruction level has been 
reported as 88-97%. This level of sensitivity results from 
the demonstration of distinctly contrasted hepatic and 
pancreatic parenchyma and the contrast difference with 
the biliary system. CT has been reported to have a sensi-
tivity of 100% for demonstrating biliary obstruction due 
to malignant infiltration in the intrahepatic or proximal 
main bile duct [3]. In addition, one of the superiorities 
of CT is density measurement (Hounsfield units [HU]), 
which can be used for lesion characterisation; this is not 
offered by other imaging methods. The present study 
aimed to perform density measurements of the lesions 
in the extrahepatic bile duct lumen detected on CT scans 
performed for biliary system pathology, and to compare 
the lesion characterisation with the pathology and/or en-
doscopic retrograde cholangiopancreatography (ERCP) 
results. 
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223 contrast-enhanced CT scans performed for bile duct 
pathologies between 2009 and 2015. Of these, 17 cases 
with a density ≥ 150 HU and a clearly known calcifica-
tion stone and nine cases with a cannula located in bile 
ducts preventing optimum measurement of lesion density 
were excluded. Thus, the study included 150 cases from 
2009-2013 for the author’s thesis, and 47 patients treated 
in 2013-2015 were added for the article. The study was 
performed retrospectively. 
CT scans were performed with a Siemens Somatom 
AR Star (Erlanger, Germany). The standard scanning pa-
rameters were 130 kVp and 83 mA, and the slice thickness 
was 5 mm; the reconstruction interval was 4 mm, and the 
pitch ratio was 1.4.
After 6-8-hours of fasting in all the patients, 2 ml/kg of 
iodised contrast agent was intravenously administered at 
4 ml/s via an automatic injector, including the hepatic 
dome and the bottom edge of the third part of the duo-
denum, to obtain contrast-enhanced sections. Non-ionic 
agents containing 200 mg/ml of iodine were used as the 
contrast agent. Images were taken at 70 seconds, the time 
of the most intensive enhancement for the liver and bili-
ary system at the portal phase following intravenous in-
jection of the contrast agent.
The densities of all the lesions from the portal phase 
sections were measured as being uninformed of pathol-
ogy and/or ERCP by using regions of interest (ROIs) via 
the software on density measurement in the device and 
HU. The ROI measurement was generally performed at 
the section with the lesion of the largest size and such that 
the lesion showed the densest appearance and the largest 
part of the lesion was covered but the calcification and 
necrosis areas were not included. 
The densities of the lesions in the lumen along the 
extrahepatic bile ducts were measured and compared 
with the pathology and/or ERCP. Lesions were evaluated 
in two main groups: benign and malignant. Along with 
the lesions, the choledochus diameter, choledochal wall 
enhancement, intrahepatic biliary tract, and gallbladder 
were evaluated, and the differences in findings were ex-
amined based on the nature of the lesion.
The choledochal wall enhancement was evaluated by 
four parameters as negative enhancement, thin regular 
enhancement (< 1.5 mm), thick regular enhancement 
(≥ 1.5 mm), and irregular enhancement (Figure 1A-C). 
The median value of the four parameters was taken as 
a statistical reference. The pancreatic duct diameter was 
evaluated as either normal or dilated. Moreover, the in-
trahepatic bile duct was evaluated as either normal or di-
lated, and the gallbladder transverse diameter > 40 mm 
was considered hydropic [4]. The appearances of cases on 
ERCP and the pathological diagnoses were considered as 
the gold standard. 
The statistical analysis was performed using SPSS 16.0 
for Windows software. Descriptive statistics for the stud-
ied variables (characteristics) were presented as mean, 
Figure 1. Axial contrast-enhanced computed tomography demonstrates 
the choledochal wall as (A) thin regular enhancement (< 1.5 mm), (B) thick 
regular enhancement (≥ 1.5 mm), and (C) thick irregular enhancement
A
B
C
Material and methods
The present study was conducted with the permission 
and approval of the Medical Ethics Committee dated 
March 16, 2012 and No. 2012/66. The study evaluated 
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standard deviation, and minimum and maximum val-
ues. Student’s t-test was used for comparing Malign and 
Benign Group means for the studied variables. For de-
termination of the linear relations among the variables, 
Pearson’s correlation analysis was carried out. The cut-off 
value of density was determined using receiver operating 
characteristic (ROC) analysis.
Results
The study was conducted with CT scans of 223 patients, 
performed to determine the bile duct pathology. However, 
17 cases with a density ≥ 150 HU and a clearly known 
calcification stone and nine cases with a cannula located 
in the bile ducts, preventing optimum measurement of 
lesion density, were excluded from the study. Ultimate-
ly, 197 cases who had optimal imaging and could not be 
diagnosed by the appearance alone were included in the 
study. 
Of the 197 patients included in the study, 93 were fe-
male (47.2%) and 104 were male (52.8%); the age of all pa-
tients ranged from 30 to 94 years (mean age: 65.31 ± 12.05 
years). The mean ages for male and female participants 
were 65.34 ± 12.41 years and 65.29 ± 11.78 years, respec-
tively. The mean ages of occurrence were 65.86 ± 12.18 
years and 64.38 ± 11.87 years for benign and malignant 
lesions, respectively, and there was no statistically signifi-
cant difference between age and lesion nature (p = 0.408).
Of the 197 lesions with nature detected by histopa-
thology and/or ERCP, 125 (63.5%) were reported as be-
nign and 72 (36.5%) were reported as malignant. Of the 
72 malignant lesions diagnosed by pathology, pancreatic 
adenocarcinoma was detected in 62, pancreatic acinar 
cell carcinoma in three, and Klatskin’s tumour in seven 
of the malignant lesions. Besides malignant lesions, some 
inflammatory pathologies (sclerosing cholangitis, n = 2) 
and strictures (due to chronic inflammation, n = 11) were 
also diagnosed by pathology. Of the 125 benign lesions 
diagnosed by ERCP, except sclerosing cholangitis (n = 2) 
and chronic inflammation (n = 11), bile duct stone was 
detected in 64 patients (mean density: 74.75 with a range 
of 43-127 HU), bile duct sludge with micro calculus in 
39 patients, biliary sludge with added infection in five pa-
tients, and hydatid cyst particles in four patients. 
Lesion accompanied by contrasted choledochal wall 
was examined in four categories (1 = negative enhance-
ment, 2 = thin diffuse enhancement (< 1.5 mm), 3 = thick 
diffuse enhancement (≥ 1.5 mm), 4 = irregular enhance-
ment). Of the cases, 82 (41.6%) were category 1, 56 (28.4%) 
were category 2, 31 (15.7%) were category 3, and 28 (14.2%) 
were category 4. The statistical correlation was performed 
by taking a median value of “2” as a reference. The evalua-
tion towards benign lesions accompanied by contrasting of 
categories 1 and 2 and malignant lesions accompanied by 
contrasting of categories 3 and 4 was found to be significant 
(p = 0.001). 
Dilatation in intrahepatic bile ducts was observed in 
95 (76%) of 125 benign cases and 66 (91.7%) of 72 malig-
nant cases. Intrahepatic bile ducts were at normal width in 
24% (n = 30) of benign lesions and 8.3% (n = 6) of malig-
nant cases. There was a statistically significant correlation 
between malignancy and the presence of dilatation in the 
intrahepatic bile ducts (p = 0.016).
The gallbladder pathologies accompanied by lesion 
nature in extrahepatic bile ducts were evaluated. For-
ty-eight (24.4%) patients were cholecystectomised. There 
was no hydrops in 84 (42.7%) of the cases. Of patients 
with hydropic gallbladder (n = 65), 30 (46.2%) had benign 
lesions and 35 (53.8%) had malignant lesions in choledo-
chal lumen. A statistical significance was found between 
the gallbladder hydrops and the nature of lesion located 
in extrahepatic bile ducts (p = 0.009).
The results from comparing CT measurements of the 
densities of extrahepatic intraductal lesions with the pa-
thology and/or ERCP findings revealed that the mean 
density was 66.67 ± 17.30 HU in benign cases (n = 125) 
(Figure 2) and 82.38 ± 13.67 HU in malignant cases 
(n = 72) (Figure 3). The ROC curve for distinguishing be-
nign lesions from malignant lesions is shown in Figure 4. 
Figure 2. Axial contrast-enhanced computed tomography demonstrates 
bile duct calculi with a density of 72 HU
Figure 3. Axial contrast-enhanced computed tomography demonstrates 
adenocarcinoma filling the lumen of the bile duct with a density of 86 HU
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A cut-off value for lesion density greater than 73.5 HU yield-
ed sensitivity and specificity values of 80.6% and 65.6%, 
respectively, for differentiation of benign and malignant 
extrahepatic biliary tract lesions (p = 0.001). The intraclass 
correlation coefficient for density measurement was 77.4% 
(95% CI: 0.710-0.839). 
Discussion
Radiological imaging methods have great importance for 
evaluating the bile ducts. The use of CT to evaluate the 
bile ducts is not common; however, its use is becoming 
more common due to the high image resolution and fast 
scanning option as well as the availability of multisection 
CT and thereby the ability to reconstruct the images and 
to obtain coronal-sagittal images. It was reported that the 
localisation of obstructive pathology could be detected at 
88-97% [3,5].
There are studies that have reported about the associ-
ation of choledochal wall thickness and the wall contour 
characteristics with malignancy. The study by Schulte 
et al. reported that a thickness ≥ 1.5 mm was abnormal 
and a choledochal wall thickness ≥ 5 mm was seen only 
in cholangiocarcinoma. The comparative analysis of the 
choledochal wall enhancement and the pancreas head 
enhancement in cases with and without bile duct pathol-
ogy revealed increased levels of enhancement in cases 
with lesions [6]. In the same study, it was demonstrated 
that wall enhancement was possible also without any le-
sions in the bile ducts. Therefore, wall enhancement alone 
does not indicate the presence of pathology. The present 
study could not evaluate wall enhancement in patients 
with no lesions because only patients with lesions in bile 
ducts were included. The stricture and wall thickness due 
to benign lesions were regular and symmetrical [7]. An 
irregular, asymmetrical wall thickness is generally seen 
in malignant lesions [8,9]. Park et al. [10] reported that 
the irregular margin and asymmetrical luminal shrink-
ing could also be present in benign lesions at a rate of 
26% and 35%, respectively. The present study (n = 197) 
examined 138 cases with fine-regular enhancement and 
negative enhancement with a thickness of < 1.5 mm and 
59 cases with thick-regular or irregular enhancement with 
a thickness of ≥ 1.5 mm. The wall thickness and enhance-
ment pattern was of malignant character in 43 (59.72%) 
of the malignant lesions (n = 72) and 16 (12.8%) of the 
benign lesions (n = 125). Malignancy was detected in 
13 (15.85%) of 82 cases with no contrasted wall. The as-
sociation between the choledochus thickness and the wall 
contour characteristics with benign-malignant nature was 
found to be statistically significant (p = 0.001).
In a study on intrahepatic bile ducts, a distinct dilata-
tion was reported in 69% of malignant lesions and 28% 
of benign lesions [1]. It was reported that there was no 
dilatation in approximately 1/3 of patients with benign 
lesions, whereas all malignant cases had dilatation. In our 
study, there was no dilatation of intrahepatic bile ducts 
in only six (8.3%) of 72 malignant cases, whereas the in-
trahepatic bile ducts were at normal width in 30 (24%) of 
125 benign lesions. 
In a study on gallbladder hydrops in patients with 
choledochal lesion (n = 50), there was a malignant lesion 
in the distal of choledochus in 11 of 12 cases with hy-
drops, and a pericholecystic abscess pressuring on cystic 
duct was observed in one case as a benign lesion [1]. In 
the present study, there was hydrops in 30 (46.2%) of these 
patients had benign lesions, and 35 (53.8%) had malig-
nant lesions in choledochal lumen. It was statistically con-
firmed that the malignant extrahepatic bile duct lesions 
are accompanied by gallbladder hydrops (p = 0.009). 
Biliary obstruction is most commonly due to chole-
docholithiasis; however, it may also occur due to other 
pathologies [7]. Stones located in bile ducts may not always 
lead to dilatation. The sensitivity of CT is low in undilat-
ed bile ducts and low-density stones [11]. The sensitivi-
ty of CT varies from 72% to 88% for detecting choledo-
chus stones [8]. Its stone attenuation varies according to 
the content. Hickmann et al. reported that a density of 
> 50 HU indicated bilirubin content and a density of 
< 50 HU indicated cholesterol content [12]. In the pres-
ent study, stone was detected in 64 (42.95%) cases and the 
stone content-density association was excluded from the 
study scope. 
We could not reach any resource information on 
measuring the density of bile duct malignancies in the 
literature; however, it has been reported that the bile duct 
density might vary considerably depending on the content 
[8,13,14]. Based on our research, there is also no literature 
information about the variability of the HU attenuation 
Figure 4. The area under the receiver operating characteristic (ROC) curve 
for distinguishing benign lesions from malignant lesions using HU was 
0.774 (95% CI: 0.710-0.839, p = 0.001) 
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value of bile duct lesions by lesion nature. Therefore, it is 
not possible for us to compare the data obtained in the 
present study with the data of other studies.
In the present study, the mean HU attenuation value 
on CT was 66.67 ± 17.30 HU for benign lesions (n = 125) 
and 82.38 ± 13.67 HU for malignant lesions (n = 72), 
detected in the bile ducts. A cut-off value greater than 
73.5 HU yielded sensitivity and specificity values of 80.6% 
and 65.6%, respectively, for differentiation of intraduct-
al malignant lesions from benign lesions. The intraclass 
correlation coefficient for HU measurement was 77.4% 
(95% CI: 0.710-0.839). When the “cut-off ” value was tak-
en as 73.5, it was found statistically significant that the 
lesions of higher density could be interpreted in favour 
of malignancy and the lesions of lower density could be 
interpreted in favour of benignity (p = 0.001). 
Conclusions
Although CT is not the main examination method for le-
sions located in the bile ducts, it provides highly beneficial 
information for determining the obstruction level in the 
presence of bile duct dilatation, detecting the intraluminal 
and extraluminal lesions, demonstrating the calcification, 
and identifying the accompanying hepatic and biliary le-
sions. 
Direct and indirect findings are guidance for the 
detection of the nature of intraluminal lesions. Among 
the indirect findings, intrahepatic bile duct dilatation, 
gallbladder hydrops is most common in malignant le-
sions. Among the direct findings, thick and irregular 
enhancement of the choledochal wall adjacent to the 
lesion and a wall thickness > 4 mm should be suggestive 
of malignant aetiology. It has been seen that lesions with 
a density > 73.5 HU have a higher possibility of malig-
nancy, except for the lesions with diffuse calcification 
(calculus). 
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